Top News Stories
Double Standard for Medical Devices Needs to Go for Patients’ Sakes
by American Association for Justice
on June 21, 2011
When a surgeon implants a cardiac stent to open a blocked artery or an infusion pump to deliver cancer medications, a patient assumes these devices have been tested on actual humans so they are known to be safe. Not so, says a recent medical study published by the Archives of Internal Medicine. A study conducted by [...]
New Blood Pumped into Fetal Heart Monitor Use
by American Association for Justice
on June 18, 2011
When a brain-injured infant is born and preventable medical error is suspected, the medical malpractice debate has been quick to focus on the usefulness of Electric Fetal Monitors. Even though the tracings may have clearly showed an infant in distress – warnings that were misread or worse, ignored, by doctors and nurses at the bedside [...]
Hill Dermaceuticals, Inc. sited for False or Misleading Representations About Derma-Smoothe/FS® Body Oil
by American Association for Justice
on June 15, 2011
Consumers rely on companies to provide accurate truthful information about the risks and benefits of medical products. In an effort to drive sales, some companies deviate from the promotional information that FDA approved for their products. This puts patients safety at risk. A recent warning letter from FDA to Hill Dermaceuticals, Inc. concerning its Derma-Smoothe/FS® [...]
Boston Scientific/Guidant Hid Problems for Defective Defibrillators
by American Association for Justice
on June 12, 2011
This past week, the US Justice Department filed a lawsuit in Minnesota federal court alleging that Guidant, now owned by Boston Scientific, intentionally hid problems with regards to its defibrillators from patients, doctors and the Food and Drug Administration (FDA). The underlying complaint alleges that Guidant knew as early as 2002 that its implantable defibrillator, [...]
AngioDynamics Receives FDA Warning for Promoting Unapproved Use of NanoKnife
by American Association for Justice
on June 6, 2011
A medical device company cannot market a product for a purpose that has not been approved by the FDA. Doing so is flatly illegal. When the FDA approves a device, it does so only for “an intended use” because the FDA believes there are sufficient safety studies to support its use for that limited purpose. [...]
Motrin Caper One Big Headache for Johnson & Johnson
by American Association for Justice
on June 3, 2011
The following is a bizarre, true story about the lengths the pharmaceutical industry will go to “put one over” on the public. According to the State of Oregon, the drug giant Johnson & Johnson hired special “shoppers” to go into stores across the country to quietly buy up defective packets of Motrin rather than alert store [...]
Whistleblower sounds alarm on Medical Provider Fraud
by American Association for Justice
on May 30, 2011
The sound of whistles blowing in the pharmaceutical industry should rightly turn health care cost reform efforts toward providers and away from victims of medical malpractice.
Consumer Reports Article Highlights Safety Risks Posed By Toning Shoes, Baltimore Defective Products Lawyer Says
by jgodwin
on May 27, 2011
Consumer Reports offered important advice earlier this week when the independent, nonprofit publication advised its readers to avoid trendy toning shoes, according to Baltimore defective products attorney Robert K. Jenner. “No less an authority than Consumer Reports has recognized the danger of toning shoes,” says Jenner, a partner in Janet, Jenner & Suggs, LLC, a nationally [...]
Toss Out Baby Safety with Technology?
by American Association for Justice
on May 23, 2011
A recently announced $3.5 million grant to Washington University School of Medicine to study the link between fetal heart decreases during labor and brain damage in newborns misses the mark. Nearly all babies born in U.S. hospitals today are monitored with electric fetal monitoring during labor, giving physicians and nurses valuable information about whether a [...]
Birth Timing a Factor in Cerebral Palsy
by American Association for Justice
on May 16, 2011
According to a major new research study, if a baby is delivered early or late, it increases the odds that the infant will develop cerebral palsy (CP). Although premature birth has long been known as a factor in cerebral palsy, this is the first study that links past-term delivery to higher CP risk.
